INT183729

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.31
First Reported 2005
Last Reported 2005
Negated 0
Speculated 0
Reported most in Body
Documents 1
Total Number 8
Disease Relevance 1.08
Pain Relevance 0.67

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

plasma membrane (Anks1b) nucleus (Anks1b) cellular_component (Anks1b)
biological_process (Anks1b) cytoplasm (Anks1b)
Anks1b (Mus musculus)
Pain Link Frequency Relevance Heat
cytokine 56 99.06 Very High Very High Very High
chemokine 8 5.00 Very Low Very Low Very Low
Inflammation 8 5.00 Very Low Very Low Very Low
Enkephalin 8 5.00 Very Low Very Low Very Low
alcohol 8 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Infection 160 97.68 Very High Very High Very High
Leishmaniasis 8 82.12 Quite High
Weight Loss 8 36.64 Quite Low
Death 24 5.00 Very Low Very Low Very Low
Communicable Diseases 16 5.00 Very Low Very Low Very Low
Meningoencephalitis 16 5.00 Very Low Very Low Very Low
Cancer 16 5.00 Very Low Very Low Very Low
Immunization 8 5.00 Very Low Very Low Very Low
Sprains And Strains 8 5.00 Very Low Very Low Very Low
Disease 8 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Mice were treated with CpG ODN fma1555 or CpG ODN 1555 (50 ?
Positive_regulation (with) of Gene_expression (treated) of CpG ODN 1555
1) Confidence 0.31 Published 2005 Journal Nucleic Acids Research Section Body Doc Link PMC1156963 Disease Relevance 0.54 Pain Relevance 0
To assess whether the number of cytokine secreting cells was dose dependent, mice were treated intraperitoneally with CpG ODN 1555 or fma1555 (30, 100 or 300 ?
Positive_regulation (intraperitoneally) of Gene_expression (treated) of fma1555 associated with cytokine
2) Confidence 0.27 Published 2005 Journal Nucleic Acids Research Section Body Doc Link PMC1156963 Disease Relevance 0 Pain Relevance 0.17
To assess whether the number of cytokine secreting cells was dose dependent, mice were treated intraperitoneally with CpG ODN 1555 or fma1555 (30, 100 or 300 ?
Positive_regulation (treated) of Gene_expression (treated) of CpG ODN 1555 associated with cytokine
3) Confidence 0.27 Published 2005 Journal Nucleic Acids Research Section Body Doc Link PMC1156963 Disease Relevance 0 Pain Relevance 0.17
RP-HPLC analysis of purified CpG ODN fma1555 was performed using an analytical 5 ?
Positive_regulation (purified) of Gene_expression (analysis) of fma1555
4) Confidence 0.27 Published 2005 Journal Nucleic Acids Research Section Body Doc Link PMC1156963 Disease Relevance 0 Pain Relevance 0
To assess whether the number of cytokine secreting cells was dose dependent, mice were treated intraperitoneally with CpG ODN 1555 or fma1555 (30, 100 or 300 ?
Positive_regulation (intraperitoneally) of Gene_expression (treated) of CpG ODN 1555 associated with cytokine
5) Confidence 0.27 Published 2005 Journal Nucleic Acids Research Section Body Doc Link PMC1156963 Disease Relevance 0 Pain Relevance 0.17
To assess whether the number of cytokine secreting cells was dose dependent, mice were treated intraperitoneally with CpG ODN 1555 or fma1555 (30, 100 or 300 ?
Positive_regulation (treated) of Gene_expression (treated) of fma1555 associated with cytokine
6) Confidence 0.27 Published 2005 Journal Nucleic Acids Research Section Body Doc Link PMC1156963 Disease Relevance 0 Pain Relevance 0.17
Mice were treated with CpG ODN fma1555 or CpG ODN 1555 (50 ?
Positive_regulation (with) of Gene_expression (treated) of fma1555
7) Confidence 0.27 Published 2005 Journal Nucleic Acids Research Section Body Doc Link PMC1156963 Disease Relevance 0.54 Pain Relevance 0
RP-HPLC analysis of purified CpG ODN fma1555 was performed using an analytical 5 ?
Positive_regulation (performed) of Gene_expression (analysis) of fma1555
8) Confidence 0.27 Published 2005 Journal Nucleic Acids Research Section Body Doc Link PMC1156963 Disease Relevance 0 Pain Relevance 0

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox